4.7 Article

The value of FDG combined with PiB PET in the diagnosis of patients with cognitive impairment in a memory clinic

期刊

CNS NEUROSCIENCE & THERAPEUTICS
卷 -, 期 -, 页码 -

出版社

WILEY
DOI: 10.1111/cns.14418

关键词

cognitive impairment; fluorodeoxyglucose; memory clinic; Pittsburgh compound B; positron emission tomography

向作者/读者索取更多资源

The study aimed to analyze the value of F-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) combined with amyloid PET in cognitive impairment diagnosis. The results showed that hypometabolism in the temporoparietal and posterior cingulate/precuneus cortex on FDG PET suggested amyloid pathology in patients with cognitive impairment. This combined approach is helpful in diagnostic decision-making and predicting the conversion from MCI to AD dementia.
AimsTo analyze the value of F-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) combined with amyloid PET in cognitive impairment diagnosis. MethodsA total of 187 patients with dementia or mild cognitive impairment (MCI) who underwent C-11-Pittsburgh compound B (PiB) and FDG PET scans in a memory clinic were included in the final analysis. ResultsAmyloid-positive and amyloid-negative dementia patient groups showed a significant difference in the proportion of individuals presenting temporoparietal cortex (p < 0.001) and posterior cingulate/precuneus cortex (p < 0.001) hypometabolism. The sensitivity and specificity of this hypometabolic pattern for identifying amyloid pathology were 72.61% and 77.97%, respectively, in patients clinically diagnosed with AD and 60.87% and 76.19%, respectively, in patients with MCI. The initial diagnosis was changed in 32.17% of patients with dementia after considering both PiB and FDG results. There was a significant difference in both the proportion of patients showing the hypometabolic pattern and PiB positivity between dementia conversion patients and patients with a stable diagnosis of MCI (p < 0.05). ConclusionTemporoparietal and posterior cingulate/precuneus cortex hypometabolism on FDG PET suggested amyloid pathology in patients with cognitive impairment and is helpful in diagnostic decision-making and predicting AD dementia conversion from MCI, particularly when combined with amyloid PET.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据